DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ advanced 1.66% to $556.75 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.46% to 7,666.60 and the Dow Jones Industrial Average rising 0.56% to 53,061.95.
This was the stock's third consecutive day of gains.
Vertex Pharmaceuticals Inc. hit a new 52-week high, surpassing its previous peak of $555.69, which the company reached on August 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. $(ABBV)$ rose 0.67% to $261.72, Krystal Biotech Inc. (KRYS) rose 1.48% to $369.23, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 3.17% to $16.74.
Trading volume (1.7 M) eclipsed its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.